| |
| |
|
| Insider
Information: |
Harrell James Archie Jr |
| Relationship: |
Chief Commercial Officer |
| City: |
Baltimore |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
36,766 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$15,813 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
36,766 |
|
|
| Total
Value |
$15,813 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
0
|
|
Stock
price went up :
|
3
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.5
|
0.0
|
| Percentage
Gain/Loss : |
 -16.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Avalo Therapeutics, Inc |
AVTX |
Chief Commercial Officer |
2021-12-10 |
36,766 |
2018-12-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AVTX |
Avalo Therapeutics, Inc |
Chief Commercial Officer |
• – – |
2021-12-10 |
4 |
B |
$1.57 |
$1,716 |
D/D |
1,093 |
36,766 |
2.66 |
% |
|
| AVTX |
Avalo Therapeutics, Inc |
Chief Commercial Officer |
• – – |
2021-06-10 |
4 |
B |
$2.28 |
$17,084 |
D/D |
7,493 |
35,673 |
2.74 |
% |
|
| AVTX |
Avalo Therapeutics, Inc |
Chief Commercial Officer |
• – – |
2020-12-10 |
4 |
B |
$2.28 |
$390 |
D/D |
171 |
28,180 |
2.66 |
% |
|
| AVTX |
Avalo Therapeutics, Inc |
Chief Commercial Officer |
• – – |
2020-06-10 |
4 |
B |
$2.28 |
$14,559 |
D/D |
6,391 |
28,009 |
2.74 |
% |
|
| AVTX |
Avalo Therapeutics, Inc |
Chief Commercial Officer |
• – – |
2020-06-09 |
4 |
B |
$2.50 |
$25,000 |
D/D |
10,000 |
21,618 |
2.74 |
% |
|
| AVTX |
Avalo Therapeutics, Inc |
Chief Commercial Officer |
• – – |
2019-12-10 |
4 |
B |
$2.85 |
$8,725 |
D/D |
3,064 |
11,618 |
2.74 |
- |
|
| AVTX |
Avalo Therapeutics, Inc |
Exec. VP, Mktg & External Comm |
• – – |
2019-06-10 |
4 |
B |
$2.85 |
$12,523 |
D/D |
4,398 |
8,554 |
2.74 |
- |
|
| AVTX |
Avalo Therapeutics, Inc |
Exec. VP, Mktg & External Comm |
• – – |
2018-12-10 |
4 |
B |
$2.85 |
$11,834 |
D/D |
4,156 |
4,156 |
2.74 |
- |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
